Загрузка...
Mesenchymal Stromal Cells Derived From Crohn's Patients Deploy Indoleamine 2,3-dioxygenase-mediated Immune Suppression, Independent of Autophagy
Autologous bone marrow-derived mesenchymal stromal cells (MSCs) for adoptive cell therapy of luminal Crohn's disease (CD) are being tested in clinical trials. However, CD is associated with dysregulation of autophagy and its effect on MSC's immunobiology is unknown. Here, we demonstrate no...
Сохранить в:
| Опубликовано в: : | Mol Ther |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Publishing Group
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4817795/ https://ncbi.nlm.nih.gov/pubmed/25899824 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2015.67 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|